In continuation to the intimation given by the Akums Drugs and Pharmaceuticals (the Company) on 14th May, 2026 and 16th May, 2026, Akums Drugs and Pharmaceuticals has informed that all the manufacturing operations at the affected sites of the Company and its Subsidiaries, situated in the state of Uttarakhand, have been successfully resumed at 100% operations capacity with effect from 18th May, 2026. The partial disruption in production at Haridwar sites lasted for four days which resulted in delayed supply of approx. INR 20 Cr. They are hopeful to make up for the production loss in the coming weeks. The details as required under the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, are provided in Annexure-1 attached.
The above information is a part of company’s filings submitted to BSE.
